Withdrawal of inhaled corticosteroids in COPD

Just breathe: a review of sex and gender in chronic lung disease

Chronic lung diseases are the third leading cause of death worldwide and are increasing in prevalence over time. Although much of our traditional understanding of health and disease is derived from study of the male of the species - be it animal or human - there is increasing evidence that sex and gender contribute to differences in disease risk, prevalence, presentation, severity, treatment approach, response and outcomes. Chronic obstructive pulmonary disease, asthma and bronchiectasis represent the most prevalent and studied chronic lung diseases and have key sex- and gender-based differences which are critical to consider and incorporate into clinical and research approaches. Mechanistic differences present opportunities for therapeutic development whereas behavioural and clinical differences on the part of patients and providers present opportunities for greater education and understanding at multiple levels. In this review, we seek to summarise the sex- and gender-based differences in key chronic lung diseases and outline the clinical and research implications for stakeholders.

Correlation and causality: a COVID-19 conundrum

I read with interest the two contributions by J.D. Chalmers and co-workers to the July issue of the European Respiratory Journal. In a reply to correspondence concerning the inhaled corticosteroid withdrawal controversy in COPD [1], they suggest that A. Agusti succumbs to the fallacy of post hoc, ergo, propter hoc [2], i.e. A occurred, then B occurred: therefore, A caused B. However, as we know, correlation is not causality.

Predictive models depend heavily on the assumptions made in their constructionhttps://bit.ly/2Eex05F